Correction: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGF R-2 signaling pathway in hepatocellular carcinoma

• Fei Teng,
• Ju-Xiang Zhang,
• Qi-Meng Chang,
• Xu-Bo Wu,
• Wei-Guo Tang,
• Jian-Fa Wang,
• Jin-Feng Feng,
• Zi-Ping Zhang,
• Zhi-Qiu Hu

Affiliations

Fei Teng

Department of Hepatobiliary and Pancreatic Surgery, Minhang Hospital, Fudan University

Ju-Xiang Zhang

Med-X Engineering Center for Medical Equipment and Technology, School of Biomedical Engineering, Shanghai Jiao Tong University

Qi-Meng Chang

Department of Hepatobiliary and Pancreatic Surgery, Minhang Hospital, Fudan University

Xu-Bo Wu

Department of Hepatobiliary and Pancreatic Surgery, Minhang Hospital, Fudan University

Wei-Guo Tang

Department of Hepatobiliary and Pancreatic Surgery, Minhang Hospital, Fudan University

Jian-Fa Wang

Department of Hepatobiliary and Pancreatic Surgery, Minhang Hospital, Fudan University

Jin-Feng Feng

Department of Hepatobiliary and Pancreatic Surgery, Minhang Hospital, Fudan University

Zi-Ping Zhang

Department of Hepatobiliary and Pancreatic Surgery, Minhang Hospital, Fudan University

Zhi-Qiu Hu

Department of Hepatobiliary and Pancreatic Surgery, Minhang Hospital, Fudan University